UBD antibody (N-Term)
Quick Overview for UBD antibody (N-Term) (ABIN634317)
Target
See all UBD AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- Ubiquitin D antibody was raised against the N terminal of UBD
-
Purification
- Affinity purified
-
Immunogen
- Ubiquitin D antibody was raised using the N terminal of UBD corresponding to a region with amino acids RSKTKVPVQDQVLLLGSKILKPRRSLSSYGIDKEKTIHLTLKVVKPSDEE
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
Ubiquitin D Blocking Peptide, (ABIN5616886), is also available for use as a blocking control in assays to test for specificity of this Ubiquitin D antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of UBD antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- UBD (Ubiquitin D (UBD))
-
Alternative Name
- Ubiquitin D
-
Background
- UBD qualifies as a marker for an interferon response in hepatocellular carcinoma and colon carcinoma but is not significantly overexpressed in cancers lacking a proinflammatory environment. Immunohistochemical studies demonstrated increased UBD expression in HIV-associated nephropathy and in autosomal dominant polycystic kidney disease.
-
Molecular Weight
- 18 kDa (MW of target protein)
-
Pathways
- Ubiquitin Proteasome Pathway
Target
-